Scynexis Inc (SCYX)

Name: Scynexis Inc (SCYX) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Scynexis Inc (SCYX)

Stock Card

$5.13

$-0.10 (-1.91%)

As on 01-Sep-2026 16:00EDT

Market cap

$54 Mln

Revenue (TTM)

$19 Mln

P/E Ratio

P/B Ratio

0.8

Div. Yield

0 %

Scynexis Inc (SCYX) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 5.11 High: 5.34

52 Week Range

Low: 3.53 High: 10.48

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.2 %
ROCE

-- %
Industry P/E

37.32
EV/EBITDA

0.1
Debt to Equity

0
Book Value

$--
EPS

$-1.8
Face value

--
Shares outstanding

9,949,609

10 Years Aggregate

CFO

$-278.01 Mln

EBITDA

$-299.16 Mln

Net Profit

$-243.43 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Scynexis Inc (SCYX)	1.4	6.0	-9.0	-22.9	-43.3	-37.1	-31.7
BSE Sensex^*	-9.9	-2.3	2.7	-5.1	5.3	5.9	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 01-Sep-2026 | *As on 02-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Scynexis Inc (SCYX)	-47.7	-45.5	42.9	-74.4	-20.3	-15.9	88.9
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Scynexis Inc (SCYX)	5.1	53.6	19.2	-10.2	-44.7	-17.6	--	0.8
Amneal Pharmaceuticals Inc Class A (AMRX)	17.7	6,109.1	3,117.6	157.4	14.7	--	37.3	190.1
Axsome Therapeutics (AXSM)	202.8	10,424.8	776.6	-191.6	-17.6	-223.4	--	129.6
BridgeBio Pharma (BBIO)	76.6	14,974.8	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	113.4	12,310.3	830.8	54.9	3.2	8.1	264.8	17.9
Dr. Reddy's Laboratories - ADR	12.2	10,087.6	332,834.2	33,166.6	11.1	8.9	28.8	2.5
Elanco Animal Health (ELAN)	23.9	11,971.8	5,020.0	-199.0	1.6	-3	--	1.8
Ligand Pharmaceuticals (LGND)	284.3	5,591.7	290.5	197.2	82.5	19.9	28.9	5.9
Liquidia Technologies Inc (LQDA)	66.9	6,058.9	450.9	138.6	39.1	115.6	50.1	32.1
Twist Bioscience Corp (TWST)	132.1	8,865.6	431.8	-136.7	-30.8	-30.3	--	21.5

Shareholding Pattern

View Details

About Scynexis Inc (SCYX)

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with... vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey. Read more

CEO, President & Director

Mr. David Gonzalez Angulo M.D.
CEO, President & Director

Dr. David Gonzalez Angulo M.D.
Headquarters

Jersey City, NJ
Website

https://www.scynexis.com

FAQs for Scynexis Inc (SCYX)

What is the current share price of Scynexis Inc (SCYX) Today?

The share price of Scynexis Inc (SCYX) is $5.13 (NASDAQ) as of 01-Sep-2026 16:00 EDT. Scynexis Inc (SCYX) has given a return of -43.31% in the last 3 years.

What is the current PB & PE ratio of Scynexis Inc (SCYX)?

Since, TTM earnings of Scynexis Inc (SCYX) is negative, P/E ratio is not available.
The P/B ratio of Scynexis Inc (SCYX) is 0.81 times as on 28-Aug-2026, a 90 discount to its peers’ median range of 7.75 times.

PE & PB ratio at the end of financial year.